MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
ElevateBio
Finance & Acquisitions: Elevate Bio
Parents
ElevateBio
Children
2019: ElevateBio announces that Allovir joins its portfolio of highly innovative cell and gene therapy companies
2021: ElevateBio adds another $525M to its war chest as it looks to build on next-gen manufacturing 'basecamp'
2021: ElevateBio Scales Disruptive Cell and Gene Therapy Business Model with $525 Million Series C Financing
2021: The Series C was led by Matrix Capital Management, SoftBank Vision Fund 2*, Fidelity Management and Research Company, MPM Capital, F2 Ventures, Redmile Group, EcoR1 Capital, Samsara BioCapital, The Invus Group, Emerson Collective, Surveyor Capital (A Citadel company), EDBI, Vertex Ventures, iTochu, and a large insurance company.
AlloVir, Inc. (NASDAQ:ALVR)*
Jumps
*Key People: Elevate Bio
Organization & Developments: Elevate Bio